Friday 21st September 2018
Dr. Victoria Flower, based in Bath, is working on a new research project, fully entitled, ‘The role of Hypoxia Inducible Factor and Vascular Endothelial Growth Factor in microvascular dysfunction and fibrosis in Systemic sclerosis’, to examine factors that may be affecting blood flow in people with Scleroderma and Raynaud’s.
Friday 14th September 2018
A team led by Sabrina Munir at King’s College London has found that the presence of single nucleotide polymorphisms (SNPs) may be indicative of Raynaud's Phenomenon or act as a measure of how likely the individual is to develop the condition.
Friday 24th August 2018
Slightly older ears may remember the days of ‘CREST’, the now outdated term for Scleroderma. But what did ‘CREST’ mean? Why was it used? And why was the term abandoned in mainstream medical practice?
Monday 20th August 2018
It’s been well established that women are more likely to be affected by Raynaud’s phenomenon than men but why? Let's look into the reasons behind this.
Thursday 10th May 2018
Tuesday 1st May 2018
Pulmonary hypertension is raised blood pressure within the pulmonary arteries, which are the blood vessels that supply the lungs.
Tuesday 27th February 2018
Calcium channel blockers can be used to treat the symptoms of Raynaud’s. A new drug, Nisoldipine, a calcium channel blocker, was tested for the treatment in Raynaud’s in a trial.
